| Date | Company | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
|---|---|---|---|---|---|---|---|---|---|---|
| 31 Jan 25 | XERS Xeris Biopharma | Common Stock | Grant | Acquire A | No | No | 0 | 185,000 | 0.00 | 1,417,561 |
| 31 Jan 25 | XERS Xeris Biopharma | Common Stock | Payment of exercise | Dispose F | No | No | 3.56 | 66,450 | 236.56 k | 1,232,561 |
| 31 Jan 25 | XERS Xeris Biopharma | Common Stock | Payment of exercise | Dispose F | No | No | 3.56 | 110,750 | 394.27 k | 1,299,011 |
| 31 Jan 25 | XERS Xeris Biopharma | Stock Appreciation Right Common Stock | Grant | Acquire A | No | No | 3.56 | 300,000 | 1.07 mm | 300,000 |
| 3 Jan 25 | XERS Xeris Biopharma | Common Stock | Payment of exercise | Dispose F | No | No | 3.61 | 32,059 | 115.73 k | 1,409,761 |
| 22 Nov 24 | XERS Xeris Biopharma | Common Stock | Option exercise | Acquire M | No | No | 1.55 | 19,483 | 30.20 k | 1,441,820 |
| 22 Nov 24 | XERS Xeris Biopharma | Stock Option Common Stock | Option exercise | Dispose M | No | No | 1.55 | 2,640 | 4.09 k | 0 |
| 22 Nov 24 | XERS Xeris Biopharma | Stock Option Common Stock | Option exercise | Dispose M | No | No | 1.55 | 16,843 | 26.11 k | 0 |
| 31 Jan 24 | XERS Xeris Biopharma | Common Stock | Grant | Acquire A | No | No | 0 | 450,000 | 0.00 | 1,626,912 |
| 20 Nov 23 | XERS Xeris Biopharma | Common Stock | Buy | Acquire P | No | No | 1.95 | 28,000 | 54.60 k | 1,176,912 |
